Fate Therapeutics (FATE) Hmangaihna Thlan
Fate Therapeutics
Thlanh chiah a ngai$2.36Updated 25 Sep 2026 19:59 UTC
Change+0.85%
AI forecast: FATE
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Lai a ngaih a hnu a 6 thlang
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Ri hlaam thlan a nih hi
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumHmi hnuai thawn
Fate Therapeutics, Inc. provides biopharmaceutical services. The company researches and develops treatments for tissue repair and regeneration using stem cells. The company operates in the United States.
